Title :

Pet imaging in patients with brain metastasis - report of the rano/pet group

Author(s) :

Galldiks, Norbert [Auteur]
Langen, Karl-Josef [Auteur]
Albert, Nathalie L. [Auteur]
Chamberlain, Marc [Auteur]
Soffietti, Riccardo [Auteur]
Kim, Michelle M. [Auteur]
Law, Ian [Auteur]
Le Rhun, Emilie [Auteur]
Chang, Susan M. [Auteur]
Schwarting, Julian [Auteur]
Combs, Stephanie E. [Auteur]
Preusser, Matthias [Auteur]
Forsyth, Peter [Auteur]
Pope, Whitney B. [Auteur]
Weller, Michael [Auteur]
Tonn, Jorg C. [Auteur]

Journal title :

Neuro-Oncology

Abbreviated title :

Neuro-oncology

Publication date :

2019-01-05

ISSN :

1523-5866

Keyword(s) :

amino acid PET
pseudoprogression
FET
FDG PET
brain metastases

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam ...
Show more >Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

INSERM
Université de Lille

Collections :

• Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192

Submission date :

2022-06-15T13:59:01Z